Cargando…

The Role of Interleukin-1-Receptor-Antagonist in Bladder Cancer Cell Migration and Invasion

Background: The interleukin-1-receptor antagonist IL1RA (encoded by the IL1RN gene) is a potent competitive antagonist to interleukin-1 (IL1) and thereby is mainly involved in the regulation of inflammation. Previous data indicated a role of IL1RA in muscle-invasive urothelial carcinoma of the bladd...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schneider, Lisa, Liu, Junnan, Zhang, Cheng, Azoitei, Anca, Meessen, Sabine, Zheng, Xi, Cremer, Catharina, Gorzelanny, Christian, Kempe-Gonzales, Sybille, Brunner, Cornelia, Wezel, Felix, Bolenz, Christian, Gunes, Cagatay, John, Axel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8198563/ https://www.ncbi.nlm.nih.gov/pubmed/34070905 http://dx.doi.org/10.3390/ijms22115875

Ejemplares similares

The Role of TKS5 in Chromosome Stability and Bladder Cancer Progression
por: Wang, Wenya, et al.
Publicado: (2022)

A Comparative Assessment of Replication Stress Markers in the Context of Telomerase
por: Meessen, Sabine, et al.
Publicado: (2022)

Grainyhead-Like 3 Influences Migration and Invasion of Urothelial Carcinoma Cells
por: Wezel, Felix, et al.
Publicado: (2021)

Shorter Leukocyte Telomere Length Is Associated with Worse Survival of Patients with Bladder Cancer and Renal Cell Carcinoma
por: Zheng, Xi, et al.
Publicado: (2021)

Loss of ORP3 induces aneuploidy and promotes bladder cancer cell invasion through deregulated microtubule and actin dynamics
por: Wang, Xue, et al.
Publicado: (2023)

Decreased Invasion of Urothelial Carcinoma of the Bladder by Inhibition of Matrix-Metalloproteinase 7
por: Bolenz, Christian, et al.
Publicado: (2018)

Protocol to use de-epithelialized porcine urinary bladder as a tissue scaffold for propagation of pancreatic cells
por: Melzer, Michael Karl, et al.
Publicado: (2022)

A Novel Tissue and Stem Cell Specific TERF1 Splice Variant Is Downregulated in Tumour Cells
por: Morcos, Yousef Ashraf Tawfik, et al.
Publicado: (2019)

Bladder cancer-derived interleukin-1 converts the vascular endothelium into a pro-inflammatory and pro-coagulatory surface
por: John, A., et al.
Publicado: (2020)

Downregulation of ORP3 Correlates with Reduced Survival of Colon Cancer Patients with Advanced Nodal Metastasis and of Female Patients with Grade 3 Colon Cancer
por: Xu, Pengfei, et al.
Publicado: (2020)

Ex vivo validation of a real-time multispectral endoscopic system for the detection and biopsy of bladder tumors
por: Grüne, Britta, et al.
Publicado: (2021)

Interleukin-1 Antagonists for the Treatment of Recurrent Pericarditis
por: Abadie, Bryan Q., et al.
Publicado: (2022)

Re: “Multiparametric cystoscopy: opportunities to enhance bladder cancer detection”
por: Kriegmair, Maximilian Christian, et al.
Publicado: (2020)

Npm1 haploinsufficiency in collaboration with MEIS1 is sufficient to induce AML in mice
por: Muranyi, Andrew, et al.
Publicado: (2022)

An Immunological Glance on Pancreatic Ductal Adenocarcinoma
por: Melzer, Michael Karl, et al.
Publicado: (2020)

Impact of an Interleukin-1 Receptor Antagonist and Erythropoietin on Experimental Myocardial Ischemia/Reperfusion Injury
por: Grothusen, Christina, et al.
Publicado: (2012)

Lithium Therapy Associated With Renal and Upper and Lower Urinary Tract Tumors: Results From a Retrospective Single-Center Analysis
por: Gahr, Maximilian, et al.
Publicado: (2019)

Contemporary options and future perspectives: three examples highlighting the challenges in testicular cancer imaging
por: Wakileh, Gamal Anton, et al.
Publicado: (2021)

A multicenter round robin test of PD-L1 expression assessment in urothelial bladder cancer by immunohistochemistry and RT-qPCR with emphasis on prognosis prediction after radical cystectomy
por: Eckstein, Markus, et al.
Publicado: (2018)

Sarcopenia as a comorbidity‐independent predictor of survival following radical cystectomy for bladder cancer
por: Mayr, Roman, et al.
Publicado: (2018)

Elevated Levels of the Anti-Inflammatory Interleukin-1 Receptor Antagonist Precede the Onset of Type 2 Diabetes: The Whitehall II Study
por: Herder, Christian, et al.
Publicado: (2009)

Genetic Determinants of Circulating Interleukin-1 Receptor Antagonist Levels and Their Association With Glycemic Traits
por: Herder, Christian, et al.
Publicado: (2014)

IL1RN and KRT13 Expression in Bladder Cancer: Association with Pathologic Characteristics and Smoking Status
por: Worst, Thomas S., et al.
Publicado: (2014)

Interleukin Expression after Injury and the Effects of Interleukin-1 Receptor Antagonist
por: Chamberlain, Connie S., et al.
Publicado: (2013)

KRT20, KRT5, ESR1 and ERBB2 Expression Can Predict Pathologic Outcome in Patients Undergoing Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-Invasive Bladder Cancer
por: Jütte, Hendrik, et al.
Publicado: (2021)

Interleukin-1 antagonists in Mevalonate Kinase Deficiency
por: Galeotti, C, et al.
Publicado: (2011)

Physiologic role of interleukin-1 receptor antagonist
por: Arend, William P, et al.
Publicado: (2000)

NF-κB controls the global pro-inflammatory response in endothelial cells: evidence for the regulation of a pro-atherogenic program
por: Kempe, Sybille, et al.
Publicado: (2005)

The interleukin-1 receptor antagonist influences interleukin-1 effects in rat and mouse
por: Bjrök, P., et al.
Publicado: (1992)

Subtype specific expression and survival prediction of pivotal lncRNAs in muscle invasive bladder cancer
por: Rinaldetti, Sebastien, et al.
Publicado: (2020)

Interleukin 1-β, Interleukin-1 Receptor Antagonist, and Interleukin 18 in Children with Acute Spontaneous Urticaria
por: Machura, E., et al.
Publicado: (2013)

Structural Mimicry of Receptor Interaction by Antagonistic Interleukin-6 (IL-6) Antibodies
por: Blanchetot, Christophe, et al.
Publicado: (2016)

Accelerated Increase in Serum Interleukin-1 Receptor Antagonist Starts 6 Years Before Diagnosis of Type 2 Diabetes: Whitehall II Prospective Cohort Study
por: Carstensen, Maren, et al.
Publicado: (2010)

Xpert bladder cancer monitor to predict the need for a second TURB (MoniTURB trial)
por: Breyer, Johannes, et al.
Publicado: (2023)

Platelets in Skin Autoimmune Diseases
por: Liu, Xiaobo, et al.
Publicado: (2019)

Crosstalk between Circulating Tumor Cells and Plasma Proteins—Impact on Coagulation and Anticoagulation
por: Wang, Yuanyuan, et al.
Publicado: (2023)

Peri- and Postoperative Treatment with the Interleukin-1 Receptor Antagonist Anakinra Is Safe in Patients Undergoing Renal Transplantation: Case Series and Review of the Literature
por: Mulders-Manders, Catharina M., et al.
Publicado: (2017)

Role of interleukin-25 in development of spontaneous arthritis in interleukin-1 receptor antagonist-deficient mice
por: Abe, Yasuharu, et al.
Publicado: (2017)

Scoping review of biological treatment of deficiency of interleukin-36 receptor antagonist (DITRA) in children and adolescents
por: Hospach, Toni, et al.
Publicado: (2019)

Subclassification, survival prediction and drug target analyses of chemotherapy-naïve muscle-invasive bladder cancer with a molecular screening
por: Rinaldetti, Sebastien, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_c4rv7p7oqh1ajf5jnhpu54sn4q